[Problems of specific secretory antiviral immunity].
D000281:Administration, Intranasal; D000284:Administration, Oral; D000336:Aerosols; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000918:Antibody Specificity; D004032:Diet; D006801:Humans; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control; D051379:Mice; D011051:Poliomyelitis / Q000276:immunology; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D012141:Respiratory Tract Infections / Q000276:immunology; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage; D014777:Virus Diseases / Q000276:immunology*
D000336:Aerosols; D000914:Antibodies, Viral; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007252:Influenza Vaccines; D011054:Poliovirus Vaccine, Inactivated; D014765:Viral Vaccines
Problemy spetsificheskogo sekretornogo protivovirusnogo immuniteta